Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Calgary

$27,000.00

Investigating the role of mitochondrial dynamics in the development of cardiac fibrosis

FY 2025-26

Summary
Cardiovascular disease (CVD) remains a leading cause of death, and many patients develop cardiac fibrosis, a form of scarring that stiffens heart muscle, impairs its ability to pump, and ultimately contributes to heart failure. In a healthy heart, cardiac fibroblasts maintain the structure around cardiomyocytes, the heart muscle cells. After injury, fibroblasts can change into activated myofibroblasts that produce large amounts of scar tissue. This response is initially protective, but when it becomes excessive, it worsens heart function and can lead to heart failure. There are currently no treatments that directly target this fibrotic process. Studies have shown that the dysregulation of mitochondrial function contributes to the development of cardiac fibrosis. Under normal conditions, mitochondria undergo merging and division processes to maintain balance in the cell. Dynamin-related protein 1 (Drp1) is a key protein that regulates mitochondrial division. When it becomes abnormally active, mitochondria become fragmented and stressed. This process has been linked to cardiac fibrosis and several CVDs. Therefore, this study will test whether mitochondrial division mediated by Drp1, specifically in cardiac fibroblasts and myofibroblasts, worsens cardiac fibrosis. To look at the role of Drp1 in cardiac fibrosis, we will use genetically modified mice with Drp1 removed from fibroblasts and myofibroblasts. These mice and normal control mice will receive surgery to induce cardiac fibrosis and heart failure. The extent of scarring, heart function, and changes in mitochondrial dynamics will be measured. Overall, by understanding the role of Drp1 in the development of cardiac fibrosis, this study aims to identify novel targets for future treatments for fibrosis in heart failure.
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
573268
Name
Nguyen Theresa T
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the role of mitochondrial dynamics in the development of cardiac fibrosis
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Cardiac Fibrosis; Dynamin Related Protein 1; Fibroblast; Heart Failure; Mitochondria; Mitochondrial Dynamics; Myofibroblast
Abstract
Cardiovascular disease (CVD) remains a leading cause of death, and many patients develop cardiac fibrosis, a form of scarring that stiffens heart muscle, impairs its ability to pump, and ultimately contributes to heart failure. In a healthy heart, cardiac fibroblasts maintain the structure around cardiomyocytes, the heart muscle cells. After injury, fibroblasts can change into activated myofibroblasts that produce large amounts of scar tissue. This response is initially protective, but when it becomes excessive, it worsens heart function and can lead to heart failure. There are currently no treatments that directly target this fibrotic process. Studies have shown that the dysregulation of mitochondrial function contributes to the development of cardiac fibrosis. Under normal conditions, mitochondria undergo merging and division processes to maintain balance in the cell. Dynamin-related protein 1 (Drp1) is a key protein that regulates mitochondrial division. When it becomes abnormally active, mitochondria become fragmented and stressed. This process has been linked to cardiac fibrosis and several CVDs. Therefore, this study will test whether mitochondrial division mediated by Drp1, specifically in cardiac fibroblasts and myofibroblasts, worsens cardiac fibrosis. To look at the role of Drp1 in cardiac fibrosis, we will use genetically modified mice with Drp1 removed from fibroblasts and myofibroblasts. These mice and normal control mice will receive surgery to induce cardiac fibrosis and heart failure. The extent of scarring, heart function, and changes in mitochondrial dynamics will be measured. Overall, by understanding the role of Drp1 in the development of cardiac fibrosis, this study aims to identify novel targets for future treatments for fibrosis in heart failure.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Nguyen, Theresa T
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~